Schedule of Earnings Per Share, Basic and Diluted |
The following table presents the reconciliation of net loss used in computing diluted net loss per share of common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Net loss |
$ |
(81,115,414) |
|
|
$ |
(84,130,722) |
|
|
$ |
(245,241,272) |
|
|
$ |
(210,705,940) |
|
Interest on convertible notes |
2,000,000 |
|
|
— |
|
|
5,977,777 |
|
|
— |
|
Change in fair value of convertible notes |
(20,600,000) |
|
|
— |
|
|
(27,600,000) |
|
|
— |
|
Adjusted net loss |
$ |
(99,715,414) |
|
|
$ |
(84,130,722) |
|
|
$ |
(266,863,495) |
|
|
$ |
(210,705,940) |
|
The following table presents the potentially dilutive shares that were excluded from the computation of diluted net loss per share of common stock, because their effect was anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Stock-based awards and warrants |
3,987,285 |
|
|
5,948,219 |
|
|
3,987,285 |
|
|
5,948,219 |
|
Convertible notes |
— |
|
|
975,881 |
|
|
— |
|
|
4,759,747 |
|
|